Skip to main content

Syndicate contentCancer Research

Vanderbilt scientists report first effective medical therapy for rare stomach disorder

A drug used to treat colorectal cancer also can reverse a rare stomach disorder and should be considered first-line therapy for the disease, researchers at Vanderbilt University Medical Center report this week.

Protein from pregnancy hormone may prevent breast cancer

PHILADELPHIA -- Researchers have found that hormones produced during pregnancy induce a protein that directly inhibits the growth of breast cancer.

Children's Hospital Oakland scientists discover soy component may be key to fighting colon cancer

November 18, 2009 - Oakland, Calif. -- A study conducted by Children's Hospital & Research Center Oakland scientists identifies a new class of therapeutic agents found naturally in soy that can prevent and possibly treat colon cancer, the third most deadly form of cancer.

New cancer target for non-Hodgkin's lymphoma

NEW YORK (Nov. 22 2009) -- Physician-scientists from Weill Cornell Medical College have discovered a molecular mechanism that may prove to be a powerful target for the treatment of non-Hodgkin's lymphoma, a type of cancer that affects lymphocytes, or white blood cells.

Researchers identify role of gene in tumor development, growth and progression

RICHMOND, Va. (Nov. 20, 2009) -- Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine researchers have identified a gene that may play a pivotal role in two processes that are essential for tumor development, growth and progression to metastasis.

Common pain relief medication may encourage cancer growth

Although morphine has been the gold-standard treatment for postoperative and chronic cancer pain for two centuries, a growing body of evidence is showing that opiate-based painkillers can stimulate the growth and spread of cancer cells.

Nanoparticles used in common household items caused genetic damage in mice

Titanium dioxide (TiO2) nanoparticles, found in everything from cosmetics to sunscreen to paint to vitamins, caused systemic genetic damage in mice, according to a comprehensive study conducted by researchers at UCLA's Jonsson Comprehensive Cancer Center.

New combination therapy could deliver powerful punch to breast cancer

AUGUSTA, Ga. -- A powerful new breast cancer treatment could result from packaging one of the newer drugs that inhibits cancer's hallmark wild growth with another that blocks a primordial survival technique in which the cancer cell eats part of itself, researchers say.

Scientists uncover new key to the puzzle of hormone therapy and breast cancer

PHILADELPHIA -- The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyper

Does green tea prevent cancer? Evidence continues to brew, but questions remain

PHILADELPHIA -- Although scientists are reluctant to officially endorse green tea as a cancer prevention method, evidence continues to grow about its protective effects, including results of a new

Experimental agent reduces breast cancer metastasis to bone

Researchers have reduced breast cancer metastasis to bone using an experimental agent to inhibit ROCK, a protein that was found to be over-expressed in metastatic breast cancer.

Childhood cancer survivors less likely to marry, Yale researchers find

Adult survivors of childhood cancer are 20 to 25 percent more likely to never marry compared with siblings and the general population, Yale School of Medicine researchers report in a new study publ

UT Southwestern researchers use drug-radiation combo to eradicate lung cancer

Researchers at UT Southwestern Medical Center have eliminated non-small cell lung (NSCL) cancer in mice by using an investigative drug called BEZ235 in combination with low-dose radiation.

Standards for a new genomic era

LOS ALAMOS, New Mexico, OCTOBER 21, 2009 -- A team of geneticists at Los Alamos National Laboratory, together with a consortium of international researchers, has recently proposed a set of standards designed to elucidate the quality of publicly available genetic sequencing information.

What drives our genes? Salk researchers map the first complete human epigenome

LA JOLLA, CA -- Although the human genome sequence faithfully lists (almost) every single DNA base of the roughly 3 billion bases that make up a human genome, it doesn't tell biologists much about how its function is regulated.



About us

Science Blog was started in August 2002. It lives, breathes and eats press releases from research organizations around the globe. Most of what you read here are press releases from the outfits named in the stories themselves. Got a news story you think belongs here? Let's talk. The other half of the equation is blog posts from readers like you. So if you have an interest in science, please register and join others like you in an ongoing, vibrant dialog about what makes the world tick. Meantime, please take a minute to read our Privacy Policy and Site Disclaimer.


Premium Drupal Themes by Adaptivethemes